フォロー
JP Amorij
JP Amorij
Vaccine Technology Expert
確認したメール アドレス: unicef.org
タイトル
引用先
引用先
Current and next generation influenza vaccines: Formulation and production strategies
PC Soema, R Kompier, JP Amorij, GFA Kersten
European Journal of Pharmaceutics and Biopharmaceutics 94, 251-263, 2015
3582015
Development of stable influenza vaccine powder formulations: challenges and possibilities
JP Amorij, A Huckriede, J Wilschut, HW Frijlink, WLJ Hinrichs
Pharmaceutical research 25, 1256-1273, 2008
2692008
A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation
V Saluja, JP Amorij, JC Kapteyn, AH De Boer, HW Frijlink, WLJ Hinrichs
Journal of Controlled Release 144 (2), 127-133, 2010
2422010
Buccal and sublingual vaccine delivery
H Kraan, H Vrieling, C Czerkinsky, W Jiskoot, G Kersten, JP Amorij
Journal of controlled release 190, 580-592, 2014
2192014
Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses …
JP Amorij, V Saluja, AH Petersen, WLJ Hinrichs, A Huckriede, HW Frijlink
Vaccine 25 (52), 8707-8717, 2007
2142007
Needle-free influenza vaccination
JP Amorij, WLJ Hinrichs, HW Frijlink, JC Wilschut, A Huckriede
The Lancet infectious diseases 10 (10), 699-711, 2010
1572010
Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach
PC Soema, GJ Willems, W Jiskoot, JP Amorij, GF Kersten
European journal of pharmaceutics and biopharmaceutics 94, 427-435, 2015
1492015
Towards tailored vaccine delivery: needs, challenges and perspectives
JP Amorij, GFA Kersten, V Saluja, WF Tonnis, WLJ Hinrichs, B Slütter, ...
Journal of Controlled Release 161 (2), 363-376, 2012
1472012
Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying
JP Amorij, J Meulenaar, WLJ Hinrichs, T Stegmann, A Huckriede, ...
Vaccine 25 (35), 6447-6457, 2007
1432007
Developments in the formulation and delivery of spray dried vaccines
G Kanojia, R Have, PC Soema, H Frijlink, JP Amorij, G Kersten
Human vaccines & immunotherapeutics 13 (10), 2364-2378, 2017
872017
Pulmonary vaccine delivery: a realistic approach?
WF Tonnis, GF Kersten, HW Frijlink, WLJ Hinrichs, AH de Boer, JP Amorij
Journal of aerosol medicine and pulmonary drug delivery 25 (5), 249-260, 2012
842012
A design of experiment approach to predict product and process parameters for a spray dried influenza vaccine
G Kanojia, GJ Willems, HW Frijlink, GFA Kersten, PC Soema, JP Amorij
International journal of pharmaceutics 511 (2), 1098-1111, 2016
832016
Influenza vaccine manufacturing: effect of inactivation, splitting and site of manufacturing. Comparison of influenza vaccine production processes
TC Kon, A Onu, L Berbecila, E Lupulescu, A Ghiorgisor, GF Kersten, ...
PloS one 11 (3), e0150700, 2016
802016
Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures
F Geeraedts, V Saluja, W ter Veer, JP Amorij, HW Frijlink, J Wilschut, ...
The AAPS journal 12, 215-222, 2010
792010
Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant
V Saluja, JP Amorij, ML van Roosmalen, K Leenhouts, A Huckriede, ...
The AAPS journal 12, 109-116, 2010
762010
Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars
WF Tonnis, JP Amorij, MA Vreeman, HW Frijlink, GF Kersten, ...
European Journal of Pharmaceutical Sciences 55, 36-45, 2014
752014
Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics
M Tafaghodi, V Saluja, GFA Kersten, H Kraan, B Slütter, JP Amorij, ...
Vaccine 30 (36), 5341-5348, 2012
742012
Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage
J de Jonge, JP Amorij, WLJ Hinrichs, J Wilschut, A Huckriede, HW Frijlink
european journal of pharmaceutical sciences 32 (1), 33-44, 2007
712007
Development of cross-protective influenza A vaccines based on cellular responses
PC Soema, E van Riet, G Kersten, JP Amorij
Frontiers in immunology 6, 237, 2015
562015
Development of thermostable lyophilized inactivated polio vaccine
H Kraan, P van Herpen, G Kersten, JP Amorij
Pharmaceutical research 31, 2618-2629, 2014
522014
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20